Abata in the News Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development Press Release April 6, 2022 Does It Matter Where You Locate Your Biopharma Anymore? Life Science Leader December 3, 2021 Treg engineers take aim at autoimmunity Nature Biotechnology November 9, 2021 Abata Therapeutics Strengthens Board of Directors Press Release July 28, 2021 A Potential Transformational Therapy for Progressive MS RealTalk MS July 21, 2021 Cell therapy startup Abata launches with $95 million in funding C&EN June 23, 2021 How Abata new strategy in non-relapsing MS? Third Rock leads $95M series A BioWorld June 23, 2021 Abata: engineering targeted Treg cell therapies with TCRs BioCentury June 23, 2021 Abata hopes to find ‘perfect fit’ with MS cell therapy after $95M series A Fierce Biotech June 23, 2021 Third Rock seeds cell therapy startup with $95M in bid to cure MS Endpoints News June 23, 2021 Load More
